FDA Reschedules Advisory Panel Meeting To Discuss OTC Birth Control

By Beth Wang / March 28, 2023 at 1:30 PM
FDA advisers on May 9 will meet to discuss HRA Pharma’s application for the first-ever over-the-counter birth control pill in the United States, the agency announced Tuesday (March 28) , five months after postponing discussions on the pill. If HRA’s oral drug, Opill, is approved, it will be a significant step toward increasing access to contraception in the wake of the Supreme Court’s landmark reversal of Roe v. Wade , women’s health experts say. Making the pill available OTC would...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.